Groupama Asset Management’s BioNTech BNTX Stock Holding History

Groupama Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3M	Sell	184,775 -261	-0.1%	-$24.6K	0.22%	68
2026 Q1	$16.4M	Sell	185,036 -4,033	-2%	-$414K	0.24%	69
2025 Q4	$18M	Sell	189,069 -4,333	-2%	-$437K	0.26%	66
2025 Q3	$19.1M	Sell	193,402 -29,823	-13%	-$3.19M	0.28%	62
2025 Q2	$23.8M	Buy	223,225 +26,681	+14%	+$2.69M	0.39%	53
2025 Q1	$18.7M	Buy	196,544 +109,819	+127%	+$12.3M	0.37%	56
2024 Q4	$9.76M	Buy	86,725 +19,994	+30%	+$2.28M	0.2%	73
2024 Q3	$6.36M	Buy	66,731 +8,779	+15%	+$807K	0.17%	95
2024 Q2	$4.66M	Buy	57,952 +50,277	+655%	+$4.6M	0.06%	134
2024 Q1	$4.01M	Sell	7,675 -24,152	-76%	-$2.32M	0.07%	152
2023 Q4	$3.36M	Buy	+31,827	New	+$3.21M	0.09%	145

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Groupama Asset Management's BNTX Position: Q2 2026 in Review

Groupama Asset Management reduced its BioNTech (BNTX) stake by 0.14% in Q2 2026, selling an estimated $24.6K and leaving 184,775 shares worth $17.3M. The position accounts for 0.22% of the portfolio, ranked #68.

Groupama Asset Management first reported a position in BNTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $23.8M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Groupama Asset Management held 184,775 shares of BioNTech worth $17.3M as of Q2 2026.
Groupama Asset Management sold 261 BioNTech shares in Q2 2026, an estimated $24.6K.
BioNTech made up 0.22% of Groupama Asset Management's portfolio in Q2 2026, its #68 holding.
Groupama Asset Management first reported a position in BioNTech in Q4 2023 and has held it in 11 quarters since.
Groupama Asset Management's BioNTech position peaked at $23.8M in Q2 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.